Plain-English translation of NCT07315061 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing a new medication called to see if it can help people with psoriatic arthritis—a condition that causes joint pain, swelling, and skin problems. Researchers will compare how well the medication works compared to a placebo (a dummy pill with no active ingredient) over 12 weeks. About 222 people will participate, and some will receive different doses of the medication to find out which works best.
Psoriatic arthritis can be painful and disabling, and while some treatments exist, doctors are always looking for new options that work better or have fewer side effects. This trial is testing whether this new treatment could become another choice for patients who need relief from their symptoms.
You likely qualify if…
You likely don't qualify if…
If you join, you'll be randomly assigned to take either the new medication or a placebo pill once daily for 12 weeks. You'll visit the study clinic multiple times so researchers can check how well the treatment is working and watch for any side effects by examining your joints and asking about your symptoms. If you're assigned to the placebo group initially, you'll have the chance to receive one of the doses of the actual medication after your first 12 weeks are complete.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
China
Phase
Testing effectiveness
Sponsor
InventisBio Co., Ltd
Enrollment target
~222 participants
Started
January 2026
Primary completion
August 2027
Age range
18 Years – 70 Years
Last updated on clinicaltrials.gov in April 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
yi liu, Dr.
West China School of Medicine
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.